Skip to main content

Chlorothiazide Sodium Injection Shortage

Last Updated: August 10, 2021
Status: Resolved

Reason for the Shortage
    • Akorn had chlorothiazide on allocation due to increased demand.
    • American Regent did not provide a reason for the shortage.
    • Fresenius Kabi has chlorothiazide injection available.
    • Mylan discontinued chlorothiazide injection in May 2020.
    • Sagent had chlorothiazide injection on shortage due to manufacturing delays.
    • Sun Pharma did not provide a reason for the shortage.
Available Products
    • Sodium Diuril injection, Akorn, 500 mg, vial, 1 count, NDC 76478-0711-40
    • Chlorothiazide injection, Akorn, 500 mg, vial, 1 count, NDC 17478-0419-40
    • Chlorothiazide injection, American Regent, 500 mg, vial, 1 count, NDC 00517-1820-01
    • Chlorothiazide injection, Fresenius Kabi, 500 mg, vial, 1 count, NDC 63323-0658-20
    • Chlorothiazide injection, Sagent, 500 mg, vial, 1 count, NDC 25021-0305-20
    • Chlorothiazide injection, Sun Pharma, 500 mg, vial, 1 count, NDC 47335-0330-40

Estimated Resupply Dates

    • All marketed presentations are available.

Updated

Updated August 10, 2021 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 6, 2020 by Michelle Wheeler, PharmD, Drug Information Specialist. © 2021, Drug Information Service, University of Utah, Salt Lake City, UT.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer